Salesforce, TJX, Nasdaq And A Health Care Stock On CNBC's 'Final Trades'
Portfolio Pulse from Avi Kapoor
On CNBC's 'Final Trades', analysts discussed Salesforce, Nasdaq, UnitedHealth, and TJX. Salesforce is expected to exceed earnings expectations, Nasdaq received a price target increase, UnitedHealth reported strong earnings, and TJX is set to release earnings soon.

August 21, 2024 | 1:12 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
TJX is set to release Q2 earnings, with expectations of 92 cents EPS and $13.31 billion in revenue.
While expectations are positive, the actual impact on TJX's stock will depend on the earnings results and market reaction.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 75
POSITIVE IMPACT
Salesforce is expected to exceed market expectations with upcoming earnings, projecting $2.36 EPS and $9.23 billion in revenue.
Analyst Rob Sechan believes Salesforce will exceed market expectations in its upcoming earnings report, which is a positive indicator for the stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Nasdaq received a price target increase from Deutsche Bank, now set at $72, with a Hold rating maintained.
The price target increase by Deutsche Bank suggests a positive outlook, which could support a short-term price increase.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
UnitedHealth reported strong Q2 earnings with $6.80 EPS, beating expectations, and revenue growth driven by Optum and UnitedHealthcare.
UnitedHealth's better-than-expected earnings and revenue growth indicate strong performance, likely supporting a positive short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 85